Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2019 Filed Jun 4, 2019 20:14 UTC |
Lee YuchunDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,659 | $0.00 Strike: $168.04 | $0.00 |
DisclosureSEC source: 0001209191-19-034233 · doc4.xml · derivative · entry 2 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,659 Underlying: Common Stock · 6,659 shares Expires 2029-05-31 F2 · derivative.exercise_date: Fully vested. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:14 UTC |
Lee YuchunDirector
|
Disposition to issuerCommon Stock | 1,801 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-034233 · doc4.xml · nonDerivative · entry 1 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,847 F1 · price: Upon the vesting of restricted stock units granted to Mr. Lee on June 1, 2018, Mr. Lee deferred the receipt of 1,801 shares of common stock and received instead 1,801 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Mr. Lee is reporting the disposition of 1,801 shares of common stock in exchange for an equal number of deferred stock units. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:16 UTC |
SACHS BRUCE IDirector
|
GrantDeferred Stock Units · Derivative | 1,801 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-034242 · doc4.xml · derivative · entry 3 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,378.063 Underlying: Common Stock · 1,801 shares Expires not disclosed F3 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs's disability or death. F1 · price: Upon the vesting of restricted stock units granted to Mr. Sachs on June 1, 2018, Mr. Sachs deferred the receipt of 1,801 shares of common stock and received instead 1,801 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Mr. Sachs is reporting the disposition of 1,801 shares of common stock in exchange for an equal number of deferred stock units. F3 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs's disability or death. F3 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs's disability or death. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:16 UTC |
SACHS BRUCE IDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,659 | $0.00 Strike: $168.04 | $0.00 |
DisclosureSEC source: 0001209191-19-034242 · doc4.xml · derivative · entry 2 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,659 Underlying: Common Stock · 6,659 shares Expires 2029-05-31 F2 · derivative.exercise_date: Fully vested. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:16 UTC |
SACHS BRUCE IDirector
|
Disposition to issuerCommon Stock | 1,801 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-034242 · doc4.xml · nonDerivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,210 F1 · price: Upon the vesting of restricted stock units granted to Mr. Sachs on June 1, 2018, Mr. Sachs deferred the receipt of 1,801 shares of common stock and received instead 1,801 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Mr. Sachs is reporting the disposition of 1,801 shares of common stock in exchange for an equal number of deferred stock units. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:17 UTC |
ULLIAN ELAINEDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,659 | $0.00 Strike: $168.04 | $0.00 |
DisclosureSEC source: 0001209191-19-034245 · doc4.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,659 Underlying: Common Stock · 6,659 shares Expires 2029-05-31 F1 · derivative.exercise_date: Fully vested. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:19 UTC |
YOUNG WILLIAM DDirector
|
GrantCommon Stock | 2,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-034251 · doc4.xml · nonDerivative · entry 1 YOUNG WILLIAM D · CIK 0001217420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,311 F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Read SEC document |
| May 30, 2019 Filed May 6, 2019 20:08 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 707 | $173.00 | $122,311.00 |
DisclosureSEC source: 0001209191-19-027688 · doc4.xml · nonDerivative · entry 4 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,625 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $173.00 (range $172.54 to $173.39). Read SEC document |
| May 24, 2019 Filed May 28, 2019 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 113,432 | $0.00 Strike: $77.31 | $0.00 |
DisclosureSEC source: 0001209191-19-033062 · doc4.xml · derivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,030 Underlying: Common Stock · 113,432 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| May 24, 2019 Filed May 28, 2019 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 113,432 | $175.10 | $19,861,943.20 |
DisclosureSEC source: 0001209191-19-033062 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,287 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $175.10 (range $175.00 to $175.71). F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 24, 2019 Filed May 28, 2019 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionCommon Stock | 113,432 | $77.31 | $8,769,427.92 |
DisclosureSEC source: 0001209191-19-033062 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:16 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 91 | $165.41 | $15,052.31 |
DisclosureSEC source: 0001209191-19-030892 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,553 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:18 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 133 | $165.41 | $21,999.53 |
DisclosureSEC source: 0001209191-19-030903 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,240 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:21 UTC |
Kewalramani ReshmaEVP and CMO
|
SaleCommon Stock | 241 | $165.41 | $39,863.81 |
DisclosureSEC source: 0001209191-19-030913 · doc4.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,736 F1 · kind: Transaction made pursuant to Dr. Kewalramani's company-approved trading plan under Rule 10b5-1. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:31 UTC |
Silva Paul MSVP & Controller
|
SaleCommon Stock | 161 | $165.41 | $26,631.01 |
DisclosureSEC source: 0001209191-19-030950 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,759 F1 · kind: Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:29 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 83 | $165.41 | $13,729.03 |
DisclosureSEC source: 0001209191-19-030947 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,003 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:37 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 61 | $165.41 | $10,090.01 |
DisclosureSEC source: 0001209191-19-030966 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,416 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:10 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,300 | $0.00 Strike: $77.31 | $0.00 |
DisclosureSEC source: 0001209191-19-028221 · doc4.xml · derivative · entry 7 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,462 Underlying: Common Stock · 2,300 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:10 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,758 | $0.00 Strike: $77.31 | $0.00 |
DisclosureSEC source: 0001209191-19-028221 · doc4.xml · derivative · entry 6 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,762 Underlying: Common Stock · 30,758 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:10 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleComomn Stock | 2,300 | $175.02 | $402,546.00 |
DisclosureSEC source: 0001209191-19-028221 · doc4.xml · nonDerivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,195 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $175.02 (range $175.00 to $175.13). Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:10 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionCommon Stock | 2,300 | $77.31 | $177,813.00 |
DisclosureSEC source: 0001209191-19-028221 · doc4.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:10 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 30,758 | $175.01 | $5,382,957.58 |
DisclosureSEC source: 0001209191-19-028221 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,195 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $175.01 (range $175.00 to $175.13). F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:10 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionCommon Stock | 30,758 | $77.31 | $2,377,900.98 |
DisclosureSEC source: 0001209191-19-028221 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:06 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,553 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-19-027685 · doc4.xml · derivative · entry 13 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,873 Underlying: Common Stock · 1,553 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:06 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 593 | $173.60 | $102,944.80 |
DisclosureSEC source: 0001209191-19-027685 · doc4.xml · nonDerivative · entry 10 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,240 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $170.28 (range $169.70 to $170.64). F9 · price: Open market sales reported on this line occurred at a weighted average price of $173.60 (range $173.29 to $174.08). Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:06 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 400 | $172.73 | $69,092.00 |
DisclosureSEC source: 0001209191-19-027685 · doc4.xml · nonDerivative · entry 9 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,833 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $170.28 (range $169.70 to $170.64). F8 · price: Open market sales reported on this line occurred at a weighted average price of $172.73 (range $172.12 to $173.12). Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:06 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 320 | $171.31 | $54,819.20 |
DisclosureSEC source: 0001209191-19-027685 · doc4.xml · nonDerivative · entry 8 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,233 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $171.31 (range $170.90 to $171.81). Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:06 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommonStock | 240 | $170.28 | $40,867.20 |
DisclosureSEC source: 0001209191-19-027685 · doc4.xml · nonDerivative · entry 7 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,553 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $170.28 (range $169.70 to $170.64). Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:06 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionCommon Stock | 1,553 | $86.52 | $134,365.56 |
DisclosureSEC source: 0001209191-19-027685 · doc4.xml · nonDerivative · entry 6 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:08 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,329 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-19-027688 · doc4.xml · derivative · entry 6 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,310 Underlying: Common Stock · 2,329 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:08 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 622 | $173.72 | $108,053.84 |
DisclosureSEC source: 0001209191-19-027688 · doc4.xml · nonDerivative · entry 5 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,003 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $173.72 (range $173.55 to $173.91). Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:08 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 500 | $171.71 | $85,855.00 |
DisclosureSEC source: 0001209191-19-027688 · doc4.xml · nonDerivative · entry 3 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,332 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $171.71 (range $171.35 to $172.16). Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:08 UTC |
Parini MichaelEVP, CL&AO
|
SaleComon Stock | 500 | $170.33 | $85,165.00 |
DisclosureSEC source: 0001209191-19-027688 · doc4.xml · nonDerivative · entry 2 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,832 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $170.33 (range $169.96 to $170.63). F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:08 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionCommon Stock | 2,329 | $86.52 | $201,505.08 |
DisclosureSEC source: 0001209191-19-027688 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:06 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,155 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-19-027685 · doc4.xml · derivative · entry 12 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,466 Underlying: Common Stock · 2,155 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:06 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 100 | $171.70 | $17,170.00 |
DisclosureSEC source: 0001209191-19-027685 · doc4.xml · nonDerivative · entry 5 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,240 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:06 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 400 | $170.72 | $68,288.00 |
DisclosureSEC source: 0001209191-19-027685 · doc4.xml · nonDerivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,340 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $170.72 (range $170.34 to $171.24). Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:06 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 457 | $169.31 | $77,374.67 |
DisclosureSEC source: 0001209191-19-027685 · doc4.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,740 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $169.31 (range $169.11 to $169.49). Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:06 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 1,198 | $168.56 | $201,934.88 |
DisclosureSEC source: 0001209191-19-027685 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,197 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $168.56 (range $168.07 to $168.97). F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:06 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionCommon Stock | 2,155 | $91.05 | $196,212.75 |
DisclosureSEC source: 0001209191-19-027685 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:06 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $77.31 | $0.00 |
DisclosureSEC source: 0001209191-19-027306 · doc4.xml · derivative · entry 7 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,520 Underlying: Common Stock · 300 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/05/2014. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:06 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,180 | $0.00 Strike: $77.31 | $0.00 |
DisclosureSEC source: 0001209191-19-027306 · doc4.xml · derivative · entry 6 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,820 Underlying: Common Stock · 10,180 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/05/2014. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:06 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 300 | $175.04 | $52,512.00 |
DisclosureSEC source: 0001209191-19-027306 · doc4.xml · nonDerivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,195 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $175.04 (range $175.00 to $175.12). Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:06 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionCommon Stock | 300 | $77.31 | $23,193.00 |
DisclosureSEC source: 0001209191-19-027306 · doc4.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:06 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 10,180 | $175.08 | $1,782,314.40 |
DisclosureSEC source: 0001209191-19-027306 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,195 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $175.08 (range $175.00 to $175.49). F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:06 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionCommon Stock | 10,180 | $77.31 | $787,015.80 |
DisclosureSEC source: 0001209191-19-027306 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:12 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,125 | $0.00 Strike: $90.29 | $0.00 |
DisclosureSEC source: 0001209191-19-025236 · doc4.xml · derivative · entry 14 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,625 Underlying: Common Stock · 2,125 shares Expires 2026-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: The option vests in 16 quarterly installments from 7/12/2016. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:12 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,250 | $0.00 Strike: $122.45 | $0.00 |
DisclosureSEC source: 0001209191-19-025236 · doc4.xml · derivative · entry 13 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,750 Underlying: Common Stock · 4,250 shares Expires 2026-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The option vests in 16 quarterly installments from 1/4/2016. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:12 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 400 | $184.42 | $73,768.00 |
DisclosureSEC source: 0001209191-19-025236 · doc4.xml · nonDerivative · entry 12 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,003 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F11 · price: Open market sales reported on this line occurred at a weighted average price of $184.42 (range $184.18 to $184.71). Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 20:12 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 100 | $183.15 | $18,315.00 |
DisclosureSEC source: 0001209191-19-025236 · doc4.xml · nonDerivative · entry 11 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,403 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.